123 related articles for article (PubMed ID: 38494820)
21. [A Case of Conversion Surgery after Nivolumab Monotherapy as Third-Line Therapy for Advanced Gastric Cancer].
Nishitani A; Noma T; Sakata K; Ikeda K; Miyazaki S
Gan To Kagaku Ryoho; 2023 Nov; 50(11):1199-1202. PubMed ID: 38056874
[TBL] [Abstract][Full Text] [Related]
22. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
23. [A Case of Long-Term Survival in a Patient with Lung Metastasis of Gastric Cancer Treated Using Curative Surgery].
Namikawa T; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kumon T; Nagata Y; Kobayashi M; Hanazaki K
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1827-1829. PubMed ID: 30692367
[TBL] [Abstract][Full Text] [Related]
24. [Advanced Gastric Cancer with Liver Metastasis and Para-Aortic Lymph Node Metastases Treated Effectively Using Neoadjuvant CapeOX Therapy].
Kidogami S; Tamura S; Endo S; Imamura H; Yoneda N; Mokutani Y; Kishimoto T; Hashimoto Y; Hirose H; Ide Y; Sasaki Y
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2366-2368. PubMed ID: 32156933
[TBL] [Abstract][Full Text] [Related]
25. [A Case of Recurrent Gastric Cancer with Long-Term Control via Two Resections and Multidisciplinary Treatment Including Nivolumab].
Bungo M; Takeno A; Hirao M; Hamakawa T; Yamamoto M; Matsui Y; Tokuyama S; Toshiyama R; Kawai K; Takahashi Y; Sakai K; Doi T; Goto K; Kato T; Takami K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1715-1717. PubMed ID: 38303183
[TBL] [Abstract][Full Text] [Related]
26. [A Case of Long-Term Survival without Recurrence after Completion of Immunotherapy Due to Response of Third- Line Nivolumab for Liver Metastasis Recurrence of Esophagogastric Junction Cancer].
Ryuzaki T; Sentsui T; Amagai H; Sasagawa S; Kobayashi S; Tsukamoto S; Koide Y; Matsubara H
Gan To Kagaku Ryoho; 2023 Oct; 50(10):1126-1129. PubMed ID: 38035852
[TBL] [Abstract][Full Text] [Related]
27. [Complete Response of Liver Metastases from a HER2-Positive Gastric Cancer Treated with Combined S-1/Trastuzumab Chemotherapy].
Oae S; Shimada S; Takano Y; Seki J; Nakahara K; Maeda C; Takehara Y; Enami Y; Sawada N; Ishida F; Kudo S
Gan To Kagaku Ryoho; 2020 May; 47(5):831-834. PubMed ID: 32408330
[TBL] [Abstract][Full Text] [Related]
28. [A Case of Postoperative Recurrence of Liver Metastasis after Gastrectomy for Gastric Cancer-No Recurrence for Five Years after Twice Liver Resections].
Fukumoto S; Yamamoto Y; Yanagawa S; Takaya M; Amioka J; Kaneko Y; Watanabe A; Nishina M; Mashima H; Sumi Y; Yamaki M; Kurayoshi M; Oshita A; Nakahara M; Noriyuki T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1895-1896. PubMed ID: 38303244
[TBL] [Abstract][Full Text] [Related]
29. [A Case of Recurrent Gastric Cancer of Multiple Organ Metastasis with Long-Term Survival Due to Multimodal Treatment].
Hasegawa T; Kubo N; Sakurai K; Kuroda K; Tashima T; Iseki Y; Murata A; Nishii T; Kodai S; Tachimori A; Shimizu S; Kanazawa A; Inoue T; Nishiguchi Y; Maeda K
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1730-1732. PubMed ID: 36732981
[TBL] [Abstract][Full Text] [Related]
30. [A Case of Esophagogastric Junction Cancer Treated Successfully with Conversion Surgery after Complete Response to Nivolumab Treatment].
Yamazaki K; Taniguchi K; Yamane M; Hattori Y; Koizumi A; Shigehara F; Takashima J; Sugimoto H; Miura F; Matsutani N; Kobayashi H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2121-2123. PubMed ID: 35045512
[TBL] [Abstract][Full Text] [Related]
31. [Two Cases of Advanced and Recurrent Gastric Cancer with Long-Term Survival Due to Successful Chemotherapy].
Hasegawa T; Sakuma T; Kinoshita H; Yoshii M; Tamura T; Nakamoto K; Nakagawa Y; Toyokawa T; Tanaka H; Muguruma K; Teraoka H; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2021 Jan; 48(1):136-138. PubMed ID: 33468746
[TBL] [Abstract][Full Text] [Related]
32. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Kang YK; Chen LT; Ryu MH; Oh DY; Oh SC; Chung HC; Lee KW; Omori T; Shitara K; Sakuramoto S; Chung IJ; Yamaguchi K; Kato K; Sym SJ; Kadowaki S; Tsuji K; Chen JS; Bai LY; Oh SY; Choda Y; Yasui H; Takeuchi K; Hirashima Y; Hagihara S; Boku N
Lancet Oncol; 2022 Feb; 23(2):234-247. PubMed ID: 35030335
[TBL] [Abstract][Full Text] [Related]
33. [A Case of Liver Metastasis 14 Years after Total Gastrectomy for Advanced Gastric Cancer].
Hara K; Yamada T; Osakabe H; Shimoda Y; Nakazono M; Nagasawa S; Kumazu Y; Hayashi T; Yoshioka E; Yokose T; Rino Y; Masuda M; Ogata T; Oshima T; Yoshikawa T
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2018-2020. PubMed ID: 30692430
[TBL] [Abstract][Full Text] [Related]
34. [A Case of Gastric Cancer Performed Curative Operation after Nivolumab].
Tamesa T; Sakai B; Suzuki A; Iwamoto R; Tokunou K; Kawaoka T; Miyahara M; Yamashita Y; Yamamoto S
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1443-1445. PubMed ID: 36733096
[TBL] [Abstract][Full Text] [Related]
35. Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy.
Watanabe H; Fujikawa H; Komori K; Kano K; Takahashi K; Yamada T; Inokuchi Y; Machida N; Yokose T; Rino Y; Masuda M; Ogata T; Oshima T
Case Rep Gastroenterol; 2021; 15(2):562-567. PubMed ID: 34616257
[TBL] [Abstract][Full Text] [Related]
36. [A case of mediastinal lymph node gastric cancer recurrence during S-1 adjuvant therapy successfully treated with cisplatin + capecitabine as second-line chemotherapy].
Hirata A; Itatsu K; Fukaya M; Ebata T; Yokoyama Y; Tsunoda N; Igami T; Sugawara G; Uehara K; Yoshioka Y; Usui H; Nagino M
Gan To Kagaku Ryoho; 2013 Apr; 40(4):519-22. PubMed ID: 23848024
[TBL] [Abstract][Full Text] [Related]
37. Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer.
Jun C; Yamauchi S; Yube Y; Egawa H; Yoshimoto Y; Kubota A; Tsuda K; Kaji S; Orita H; Oka S; Mine S; Fukunaga T
Surg Case Rep; 2023 May; 9(1):86. PubMed ID: 37204618
[TBL] [Abstract][Full Text] [Related]
38. Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report.
Arigami T; Matsushita D; Okubo K; Tanaka T; Sasaki K; Noda M; Kita Y; Mori S; Tsuruda Y; Kurahara H; Ohtsuka T
Surg Case Rep; 2020 Oct; 6(1):271. PubMed ID: 33074364
[TBL] [Abstract][Full Text] [Related]
39. [A Case of Conversion Surgery after SOX plus Nivolumab for Unresectable Advanced Gastric Cancer].
Sato T; Kawaoka T; Xaolin Y; Matsukuma S; Tokunou K; Yamamoto S
Gan To Kagaku Ryoho; 2024 Jan; 51(1):75-77. PubMed ID: 38247097
[TBL] [Abstract][Full Text] [Related]
40. [Long-Term Survival of a Patient with Advanced Antral Gastric Cancer Successfully Treated with Multidisciplinary Therapy].
Hirao T; Yamamoto K; Oka Y; Takada N; Murao S; Higashiguchi M; Takeda T; Noguchi K; Danno K; Toyoda Y; Nakane S; Yamamoto H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1560-1562. PubMed ID: 38303341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
